Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
JAMA|December 11, 2023
Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT-4 Randomized Clinical TrialLouis J Aronne, Naveed Sattar, Deborah B Horn, et al.
The New England Journal of Medicine|September 17, 2025
Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity TreatmentSean Wharton, Louis J Aronne, Adam Stefanski, et al.
Lancet (London, England)|June 29, 2023
Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trialW Timothy Garvey, Juan P Frias, Ania M Jastreboff, et al.
Obesity (Silver Spring, Md.)|April 25, 2025
Perceptions of anti-obesity medications among people with obesity and healthcare providers in the US: Findings from the OBSERVE StudyLee M Kaplan, Kimberly Gudzune, Jamy Ard, et al.
Expert Review of Gastroenterology & Hepatology|October 4, 2023
Stratification of obesity phenotypes to optimize future therapy (SOPHIA)Abd A Tahrani, Marina Panova-Noeva, Nanette C Schloot, et al.
The New England Journal of Medicine|November 13, 2024
Tirzepatide for Obesity Treatment and Diabetes PreventionAnia M Jastreboff, Carel W le Roux, Adam Stefanski, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|June 20, 2024
Weight-Reduction Preferences Among OBSERVE Study Participants With Obesity or Overweight: Opportunities for Shared Decision-MakingKimberly A Gudzune, Lee M Kaplan, Scott Kahan, et al.
Pageof 3